• Publications
  • Influence
Novel psychoactive substances of interest for psychiatry
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine‐likeExpand
The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis.
Based on current diagnostic constructs, and a critical interpretation of results, both qualitative and quantitative syntheses of the evidence prompt out the relevance of differences rather similarities between BD and BPD. Expand
Characteristics of deaths associated with kratom use
These findings add substantially to the knowledge base on kratom-associated deaths and provide a ‘state-of-the-art’ review of the characteristics of such fatalities and toxic and fatal levels require quantification. Expand
Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces
This work aimed here at reviewing data relating to the profile of the online drug customer and at describing drug vending websites. Expand
Novel psychoactive substances: the pharmacology of stimulants and hallucinogens
The paper aims at providing an overview of the clinical pharmacological issues related to some of the most popular NPS categories, e.g. stimulants and hallucinogens, to inform better tailored management/treatment strategies. Expand
NPS: Medical Consequences Associated with Their Intake.
The present chapter aims at providing an overview of the clinical and pharmacological issues relating to these most popular NPS categories, including synthetic cathinones, synthetic cannabinoids, and psychedelics/phenethylamines. Expand
Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review
The importance of alexithymia screening in everyday clinical practice and the evaluation of clinical correlates of aLexithymic traits should be integral parts of all disease management programs and of suicide prevention plans and interventions. Expand
Mind Navigators of Chemicals' Experimenters? A Web-Based Description of E-Psychonauts
The e-psychonauts seemed to "test" and at times synthesize a range of drugs to achieve the state of consciousness they find most pleasurable, and there is the need to improve both the existing levels of professionals' knowledge on this novel generation of drug misusers and to design and develop novel prevention approaches that are able to attract the attention of the e-Psychonauts. Expand
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
Overall, SAMe is a well-tolerated medication, which may offer considerable advantages as an alternative to antidepressant drugs or as an add-on therapy in the treatment of MDD and TRD. Expand
Mental Health Interventions during the COVID-19 Pandemic: A Conceptual Framework by Early Career Psychiatrists
Sixteen early career psychiatrists across the world developed a preliminary conceptual framework (CF) which may help to guide the design, implementation and evaluation of MH interventions during the ongoing pandemic. Expand